P34152 (FAK1_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 156.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Focal adhesion kinase 1 Short name=FADK 1 EC=2.7.10.2 Alternative name(s): Focal adhesion kinase-related nonkinase Short name=FRNK Protein-tyrosine kinase 2 p125FAK pp125FAK | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 1090 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Non-receptor protein-tyrosine kinase that plays an essential role in regulating cell migration, adhesion, spreading, reorganization of the actin cytoskeleton, formation and disassembly of focal adhesions and cell protrusions, cell cycle progression, cell proliferation and apoptosis. Required for early embryonic development and placenta development. Required for embryonic angiogenesis, normal cardiomyocyte migration and proliferation, and normal heart development. Regulates axon growth and neuronal cell migration, axon branching and synapse formation; required for normal development of the nervous system. Plays a role in osteogenesis and differentiation of osteoblasts. Functions in integrin signal transduction, but also in signaling downstream of numerous growth factor receptors, G-protein coupled receptors (GPCR), EPHA2, netrin receptors and LDL receptors. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascade. Promotes activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling cascade. Promotes localized and transient activation of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), and thereby modulates the activity of Rho family GTPases. Signaling via CAS family members mediates activation of RAC1. Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ACTN1, ARHGEF7, GRB7, RET and WASL. Promotes phosphorylation of PXN and STAT1; most likely PXN and STAT1 are phosphorylated by a SRC family kinase that is recruited to autophosphorylated PTK2/FAK1, rather than by PTK2/FAK1 itself. Promotes phosphorylation of BCAR1; GIT2 and SHC1; this requires both SRC and PTK2/FAK1. Promotes phosphorylation of BMX and PIK3R1. Isoform 9 (FRNK) does not contain a kinase domain and inhibits PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can attenuate the nuclear accumulation of LPXN and limit its ability to enhance serum response factor (SRF)-dependent gene transcription By similarity. Ref.9 Ref.12 Ref.15 Ref.19 Ref.21 Ref.22 Ref.23 Ref.26 Ref.28 Ref.34 Ref.35 Ref.36 Ref.37 Ref.40 Ref.43 Ref.44 Ref.45 |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. Ref.1 Ref.11 Ref.19 |
| Enzyme regulation | Subject to autoinhibition, mediated by interactions between the FERM domain and the kinase domain. Activated by autophosphorylation at Tyr-428. This promotes interaction with SRC and phosphorylation at Tyr-614 and Tyr-615 in the kinase activation loop by SRC. Phosphorylation at Tyr-428, Tyr-614 and Tyr-615 is required for maximal kinase activity. Ref.11 |
| Subunit structure | Interacts with GIT1. Component of a complex that contains at least FER, CTTN and PTK2/FAK1. Interacts with BMX. Interacts with STEAP4. Interacts with ZFYVE21. Interacts with ESR1. Interacts with FGR, FLT4 and RET. Interacts with EPHA2 in resting cells; activation of EPHA2 recruits PTPN11, leading to dephosphorylation of PTK2/FAK1 and dissociation of the complex. Interacts with EPHA1 (kinase activity-dependent) By similarity. Interacts with PIAS1. Interacts with ARHGAP26 and SHC1. Interacts with RB1CC1; this inhibits PTK2/FAK1 activity and activation of downstream signaling pathways. Interacts with P53/TP53. Interacts with STAT1. Interacts with WASL. Interacts with ARHGEF7. Interacts with DCC. Interacts (via first Pro-rich region) with CAS family members (via SH3 domain), including BCAR1, BCAR3, CASS4 and NEDD9. Interacts with SORBS1. Interacts with ARHGEF28. Interacts with SHB. Interacts with PXN and TLN1. Interacts with TGFB1I1. Interacts with PIK3R1 or PIK3R2. Interacts with SRC, GRB2 and GRB7. Interacts with LPXN (via LD motif 3). Ref.9 Ref.10 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.18 Ref.20 Ref.22 Ref.25 Ref.27 Ref.28 Ref.29 Ref.30 Ref.31 Ref.32 Ref.33 Ref.37 Ref.40 Ref.43 Ref.48 |
| Subcellular location | Cell junction › focal adhesion. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm › perinuclear region. Cytoplasm › cytoskeleton. Cytoplasm › cytoskeleton › centrosome. Nucleus By similarity. Note: Constituent of focal adhesions. Detected at microtubules. Ref.1 Ref.26 Ref.40 |
| Developmental stage | Isoform 9 is detected in neonate myocardium; levels are low directly after birth, high five to fifteen days after birth, and not detectable in adult (at protein level). Isoform 9 is detected in neonate myocardium; levels are high directly after birth, decrease during the first week of life and are low thereafter. Ref.42 |
| Domain | The first Pro-rich domain interacts with the SH3 domain of CAS family members, such as BCAR1 and NEDD9. The C-terminal region is the site of focal adhesion targeting (FAT) sequence which mediates the localization of FAK1 to focal adhesions. |
| Post-translational modification | Phosphorylated on tyrosine residues upon activation, e.g. upon integrin signaling. Tyr-428 is the major autophosphorylation site, but other kinases can also phosphorylate this residue. Phosphorylation at Tyr-428 promotes interaction with SRC and SRC family members, leading to phosphorylation at Tyr-614, Tyr-615 and at additional tyrosine residues. FGR promotes phosphorylation at Tyr-428 and Tyr-614. FER promotes phosphorylation at Tyr-615, Tyr-899 and Tyr-963, even when cells are not adherent. Tyr-428, Tyr-614 and Ser-760 are phosphorylated only when cells are adherent. Phosphorylation at Tyr-428 is important for interaction with BMX, PIK3R1 and SHC1. Phosphorylation at Tyr-963 is important for interaction with GRB2. Dephosphorylated by PTPN11; PTPN11 is recruited to PTK2 via EPHA2 (tyrosine phosphorylated). Microtubule-induced dephosphorylation at Tyr-428 is crucial for the induction of focal adhesion disassembly; this dephosphorylation could be catalyzed by PTPN11 and regulated by ZFYVE21. Ref.1 Ref.6 Ref.9 Ref.11 Ref.13 Ref.14 Ref.15 Ref.19 Ref.21 Ref.24 Ref.26 Ref.31 Sumoylated; this enhances autophosphorylation By similarity. |
| Disruption phenotype | Embryonically lethal. Embryos die at about 8.5 dpc, despite normal implantation. Embryos do not develop a normal head fold, neural tube or heart tube. Endothelial-specific gene disruption is lethal at about 11 dpc, due to defects in embryonic angiogenesis. Ref.12 Ref.34 Ref.36 Ref.40 |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. FAK subfamily. Contains 1 FERM domain. Contains 1 protein kinase domain. |
| Sequence caution | The sequence BAC37757.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. The sequence BAD90317.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. Isoform 6: The sequence BC030180 differs from that shown. Reason: a stop codon in position 912 which was translated as Trp to extend the sequence |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Bcar1 | Q61140 | 2 | EBI-77070,EBI-77088 | |
| Ephb2 | P54763 | 3 | EBI-77070,EBI-537711 |
Alternative products
| This entry describes 9 isoforms produced by alternative promoter usage and alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P34152-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P34152-2) The sequence of this isoform differs from the canonical sequence as follows: 443-450: KSYGIDEA → T | ||||||
| Isoform 3 (identifier: P34152-3) The sequence of this isoform differs from the canonical sequence as follows: 393-423: Missing. 443-450: KSYGIDEA → T | ||||||
| Note: Peptide 386-413 identified and sequenced in Ref.6. | ||||||
| Isoform 4 (identifier: P34152-4) The sequence of this isoform differs from the canonical sequence as follows: 393-423: Missing. 443-450: KSYGIDEA → T 941-941: K → KPWR | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 5 (identifier: P34152-5) The sequence of this isoform differs from the canonical sequence as follows: 392-392: S → SGVS 942-954: LQPQEISPPPTAN → VGICACAMWSVPC 955-1090: Missing. | ||||||
| Isoform 6 (identifier: P34152-6) The sequence of this isoform differs from the canonical sequence as follows: 393-423: Missing. 443-450: KSYGIDEA → T 942-954: LQPQEISPPPTAN → VGICACAMWSVPC 955-1090: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 7 (identifier: P34152-7) The sequence of this isoform differs from the canonical sequence as follows: 393-417: Missing. 511-534: LTMRQFDHPHIVKLIGVITENPVW → SEVIFASKKIQLGPGIFDIICLSA 535-1090: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 8 (identifier: P34152-8) The sequence of this isoform differs from the canonical sequence as follows: 199-1090: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 9 (identifier: P34152-9) Also known as: FRNK; The sequence of this isoform differs from the canonical sequence as follows: 1-730: Missing. | ||||||
| Note: Produced by alternative promoter usage. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||
Molecule processing | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.6 | |||||||||||||||||
| Chain | 2 – 1090 | 1089 | Focal adhesion kinase 1 | PRO_0000088078 | ||||||||||||||||
Regions | ||||||||||||||||||||
| Domain | 35 – 355 | 321 | FERM | |||||||||||||||||
| Domain | 469 – 718 | 250 | Protein kinase | |||||||||||||||||
| Nucleotide binding | 466 – 472 | 7 | ATP By similarity | |||||||||||||||||
| Nucleotide binding | 538 – 540 | 3 | ATP By similarity | |||||||||||||||||
| Region | 745 – 1090 | 346 | Interaction with TGFB1I1 By similarity | |||||||||||||||||
| Region | 950 – 1090 | 141 | Interaction with ARHGEF28 | |||||||||||||||||
| Compositional bias | 750 – 771 | 22 | Pro-rich | |||||||||||||||||
| Compositional bias | 901 – 951 | 51 | Pro-rich | |||||||||||||||||
Sites | ||||||||||||||||||||
| Active site | 584 | 1 | Proton acceptor By similarity | |||||||||||||||||
| Binding site | 492 | 1 | ATP By similarity | |||||||||||||||||
Amino acid modifications | ||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.6 | |||||||||||||||||
| Modified residue | 5 | 1 | Phosphotyrosine By similarity | |||||||||||||||||
| Modified residue | 13 | 1 | Phosphothreonine By similarity | |||||||||||||||||
| Modified residue | 29 | 1 | Phosphoserine By similarity | |||||||||||||||||
| Modified residue | 428 | 1 | Phosphotyrosine; by autocatalysis Ref.11 Ref.13 Ref.19 Ref.21 Ref.24 | |||||||||||||||||
| Modified residue | 438 | 1 | Phosphotyrosine Ref.11 Ref.24 | |||||||||||||||||
| Modified residue | 608 | 1 | Phosphotyrosine By similarity | |||||||||||||||||
| Modified residue | 614 | 1 | Phosphotyrosine; by RET and SRC Ref.11 Ref.19 Ref.24 Ref.39 Ref.41 | |||||||||||||||||
| Modified residue | 615 | 1 | Phosphotyrosine; by RET and SRC Ref.11 Ref.19 Ref.24 Ref.39 Ref.41 | |||||||||||||||||
| Modified residue | 618 | 1 | Phosphoserine By similarity | |||||||||||||||||
| Modified residue | 760 | 1 | Phosphoserine By similarity | |||||||||||||||||
| Modified residue | 770 | 1 | Phosphoserine; by CDK5 Ref.26 | |||||||||||||||||
| Modified residue | 899 | 1 | Phosphotyrosine Ref.24 | |||||||||||||||||
| Modified residue | 948 | 1 | Phosphoserine Ref.6 Ref.38 | |||||||||||||||||
| Modified residue | 952 | 1 | Phosphothreonine By similarity | |||||||||||||||||
| Modified residue | 963 | 1 | Phosphotyrosine; by SRC Ref.9 Ref.14 Ref.15 Ref.24 Ref.41 | |||||||||||||||||
| Cross-link | 152 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) By similarity | ||||||||||||||||||
Natural variations | ||||||||||||||||||||
| Alternative sequence | 1 – 730 | 730 | Missing in isoform 9. | VSP_042171 | ||||||||||||||||
| Alternative sequence | 199 – 1090 | 892 | Missing in isoform 8. | VSP_033998 | ||||||||||||||||
| Alternative sequence | 392 | 1 | S → SGVS in isoform 5. | VSP_033999 | ||||||||||||||||
| Alternative sequence | 393 – 423 | 31 | Missing in isoform 3, isoform 4 and isoform 6. | VSP_004975 | ||||||||||||||||
| Alternative sequence | 393 – 417 | 25 | Missing in isoform 7. | VSP_034000 | ||||||||||||||||
| Alternative sequence | 443 – 450 | 8 | KSYGIDEA → T in isoform 2, isoform 3, isoform 4 and isoform 6. | VSP_004976 | ||||||||||||||||
| Alternative sequence | 511 – 534 | 24 | LTMRQ…ENPVW → SEVIFASKKIQLGPGIFDII CLSA in isoform 7. | VSP_034001 | ||||||||||||||||
| Alternative sequence | 535 – 1090 | 556 | Missing in isoform 7. | VSP_034002 | ||||||||||||||||
| Alternative sequence | 941 | 1 | K → KPWR in isoform 4. | VSP_034003 | ||||||||||||||||
| Alternative sequence | 942 – 954 | 13 | LQPQE…PPTAN → VGICACAMWSVPC in isoform 5 and isoform 6. | VSP_034004 | ||||||||||||||||
| Alternative sequence | 955 – 1090 | 136 | Missing in isoform 5 and isoform 6. | VSP_034005 | ||||||||||||||||
Experimental info | ||||||||||||||||||||
| Mutagenesis | 428 | 1 | Y → F: Strongly reduced enzyme activity; when associated with 614-F-F-615. Abolishes activation of MAPK1/ERK2 in response to integrin signaling. Abolishes activation of SRC. Abolishes interaction with PIK3R1. Ref.11 Ref.13 Ref.19 | |||||||||||||||||
| Mutagenesis | 614 – 615 | 2 | YY → FF: Strongly reduced enzyme activity; when associated with F-428. | |||||||||||||||||
| Mutagenesis | 963 | 1 | Y → F: Abolishes interaction with GRB2. Ref.9 Ref.14 | |||||||||||||||||
| Mutagenesis | 1072 | 1 | L → S: Loss of interaction with ARHGEF28. Ref.28 | |||||||||||||||||
| Sequence conflict | 32 | 1 | A → T in BC030180. Ref.5 | |||||||||||||||||
| Sequence conflict | 42 | 1 | Y → H in AAA37592. Ref.1 | |||||||||||||||||
| Sequence conflict | 87 | 1 | L → V in BAB24058. Ref.3 | |||||||||||||||||
| Sequence conflict | 128 | 1 | Y → D in BAB24058. Ref.3 | |||||||||||||||||
| Sequence conflict | 146 | 1 | F → V in BAB24058. Ref.3 | |||||||||||||||||
| Sequence conflict | 157 | 1 | Q → L in BC030180. Ref.5 | |||||||||||||||||
| Sequence conflict | 225 | 1 | Q → H in BAC37757. Ref.3 | |||||||||||||||||
| Sequence conflict | 250 | 1 | V → M in BAC37757. Ref.3 | |||||||||||||||||
| Sequence conflict | 800 | 1 | Q → P in BC030180. Ref.5 | |||||||||||||||||
Secondary structure | ||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||
| Helix | 960 – 980 | 21 | ||||||||||||||||||
| Helix | 985 – 987 | 3 | ||||||||||||||||||
| Helix | 989 – 1009 | 21 | ||||||||||||||||||
| Helix | 1010 – 1012 | 3 | ||||||||||||||||||
| Helix | 1018 – 1044 | 27 | ||||||||||||||||||
| Helix | 1048 – 1081 | 34 | ||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin." Hanks S.K., Calalb M.B., Harper M.C., Patel S.K. Proc. Natl. Acad. Sci. U.S.A. 89:8487-8491(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PHOSPHORYLATION. Strain: BALB/c. Tissue: Embryo. |
| [2] | "Focal adhesion kinase." Yamakawa N. Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5 AND 7). Strain: BALB/c. Tissue: Brain and Embryo. |
| [3] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 8). Strain: C57BL/6J. Tissue: Placenta and Thymus. |
| [4] | "Prediction of the coding sequences of mouse homologues of KIAA gene. The complete nucleotide sequences of mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries." Okazaki N., Kikuno R.F., Ohara R., Inamoto S., Nagase T., Ohara O., Koga H. Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Fetal brain. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6). Strain: Czech II. Tissue: Mammary tumor. |
| [6] | Bienvenut W.V., Sandilands E., Serrels B., Brunton V.G., Sumpton D.P., Frame M.C. Submitted (MAR-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-19; 39-57; 77-86; 92-121; 132-177; 179-204; 210-218; 222-259; 313-319; 350-381; 465-492; 504-546; 589-616; 622-635; 666-703; 707-728; 735-762; 836-876; 885-971; 942-971; 980-993; 1001-1019 AND 1027-1082, PROTEIN SEQUENCE OF 386-451 (ISOFORM 3), CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, PHOSPHORYLATION AT SER-948, MASS SPECTROMETRY. Tissue: Embryonic fibroblast. |
| [7] | "Alternatively spliced focal adhesion kinase in rat brain with increased autophosphorylation activity." Burgaya F., Toutant M., Studler J.-M., Costa A., Le Bert M., Gelman M., Girault J.A. J. Biol. Chem. 272:28720-28725(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 391-460 (ISOFORMS 1 AND 2). Strain: ICR X Swiss Webster. |
| [8] | Asano H., Komiyama H.K., Grant S.G. Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 391-417. Strain: 129/SvJ. |
| [9] | "Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase." Schlaepfer D.D., Hanks S.K., Hunter T., van der Geer P. Nature 372:786-791(1994) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN INTEGRIN SIGNALING AND ACTIVATION OF MAP KINASES, INTERACTION WITH GRB2; BCAR1; SHC1 AND SRC, PHOSPHORYLATION AT TYR-963, MUTAGENESIS OF TYR-963. |
| [10] | "Interaction of focal adhesion kinase with cytoskeletal protein talin." Chen H.C., Appeddu P.A., Parsons J.T., Hildebrand J.D., Schaller M.D., Guan J.L. J. Biol. Chem. 270:16995-16999(1995) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TLN1. |
| [11] | "Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases." Calalb M.B., Polte T.R., Hanks S.K. Mol. Cell. Biol. 15:954-963(1995) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT TYR-428; TYR-438; TYR-614 AND TYR-615, AUTOPHOSPHORYLATION, CATALYTIC ACTIVITY, MUTAGENESIS OF TYR-428 AND 614-TYR-615, ENZYME REGULATION. |
| [12] | "Mesodermal defect in late phase of gastrulation by a targeted mutation of focal adhesion kinase, FAK." Furuta Y., Ilic D., Kanazawa S., Takeda N., Yamamoto T., Aizawa S. Oncogene 11:1989-1995(1995) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE, FUNCTION. |
| [13] | "Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase." Chen H.C., Appeddu P.A., Isoda H., Guan J.L. J. Biol. Chem. 271:26329-26334(1996) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PIK3R1, MUTAGENESIS OF TYR-428, PHOSPHORYLATION AT TYR-428. |
| [14] | "Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases." Schlaepfer D.D., Hunter T. Mol. Cell. Biol. 16:5623-5633(1996) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT TYR-963, MUTAGENESIS OF TYR-963, INTERACTION WITH GRB2. |
| [15] | "Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src." Schlaepfer D.D., Hunter T. J. Biol. Chem. 272:13189-13195(1997) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF SHC1 AND ACTIVATION OF MAPK1/ERK2, PHOSPHORYLATION AT TYR-963, INTERACTION WITH GRB2. |
| [16] | "Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions." Matsuya M., Sasaki H., Aoto H., Mitaka T., Nagura K., Ohba T., Ishino M., Takahashi S., Suzuki R., Sasaki T. J. Biol. Chem. 273:1003-1014(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TGFB1I1. |
| [17] | "A role for CAP, a novel, multifunctional Src homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions." Ribon V., Herrera R., Kay B.K., Saltiel A.R. J. Biol. Chem. 273:4073-4080(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SORBS1. |
| [18] | "Interaction of Hic-5, A senescence-related protein, with focal adhesion kinase." Fujita H., Kamiguchi K., Cho D., Shibanuma M., Morimoto C., Tachibana K. J. Biol. Chem. 273:26516-26521(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TGFB1I1. |
| [19] | "Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2." Owen J.D., Ruest P.J., Fry D.W., Hanks S.K. Mol. Cell. Biol. 19:4806-4818(1999) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN CELL SPREADING; MIGRATION AND PHOSPHORYLATION OF BCAR1, CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION, MUTAGENESIS OF TYR-428 AND 614-TYR-TYR-615, PHOSPHORYLATION AT TYR-428; TYR-614 AND TYR-615. |
| [20] | "p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor." Gotoh T., Cai D., Tian X., Feig L.A., Lerner A. J. Biol. Chem. 275:30118-30123(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH BCAR3. |
| [21] | "FAK integrates growth-factor and integrin signals to promote cell migration." Sieg D.J., Hauck C.R., Ilic D., Klingbeil C.K., Schaefer E., Damsky C.H., Schlaepfer D.D. Nat. Cell Biol. 2:249-256(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, PHOSPHORYLATION AT TYR-428. |
| [22] | "Focal adhesion kinase activates Stat1 in integrin-mediated cell migration and adhesion." Xie B., Zhao J., Kitagawa M., Durbin J., Madri J.A., Guan J.L., Fu X.Y. J. Biol. Chem. 276:19512-19523(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH STAT1, FUNCTION IN STAT1 PHOSPHORYLATION. |
| [23] | "The cytoskeletal/non-muscle isoform of alpha-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase." Izaguirre G., Aguirre L., Hu Y.P., Lee H.Y., Schlaepfer D.D., Aneskievich B.J., Haimovich B. J. Biol. Chem. 276:28676-28685(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF ACTN1. |
| [24] | "Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies." Nakamura K., Yano H., Schaefer E., Sabe H. Oncogene 20:2626-2635(2001) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT TYR-428; TYR-438; TYR-614; TYR-615; TYR-899 AND TYR-963. |
| [25] | "Regulation of focal adhesion kinase by a novel protein inhibitor FIP200." Abbi S., Ueda H., Zheng C., Cooper L.A., Zhao J., Christopher R., Guan J.L. Mol. Biol. Cell 13:3178-3191(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RB1CC1. |
| [26] | "Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration." Xie Z., Sanada K., Samuels B.A., Shih H., Tsai L.H. Cell 114:469-482(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-770. |
| [27] | "The Shb adaptor protein causes Src-dependent cell spreading and activation of focal adhesion kinase in murine brain endothelial cells." Holmqvist K., Cross M.J., Riley D., Welsh M. Cell. Signal. 15:171-179(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SHB. |
| [28] | "Direct interaction of focal adhesion kinase with p190RhoGEF." Zhai J., Lin H., Nie Z., Wu J., Canete-Soler R., Schlaepfer W.W., Schlaepfer D.D. J. Biol. Chem. 278:24865-24873(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH ARHGEF28, MUTAGENESIS OF LEU-1072. |
| [29] | "PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation." Kadare G., Toutant M., Formstecher E., Corvol J.C., Carnaud M., Boutterin M.C., Girault J.A. J. Biol. Chem. 278:47434-47440(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PIAS1. |
| [30] | "Leupaxin is a critical adaptor protein in the adhesion zone of the osteoclast." Gupta A., Lee B.S., Khadeer M.A., Tang Z., Chellaiah M., Abu-Amer Y., Goldknopf J., Hruska K.A. J. Bone Miner. Res. 18:669-685(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH LPXN. |
| [31] | "Focal adhesion kinase regulation of N-WASP subcellular localization and function." Wu X., Suetsugu S., Cooper L.A., Takenawa T., Guan J.L. J. Biol. Chem. 279:9565-9576(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH WASL, PHOSPHORYLATION OF WASL. |
| [32] | "Focal adhesion kinase in netrin-1 signaling." Ren X.R., Ming G.L., Xie Y., Hong Y., Sun D.M., Zhao Z.Q., Feng Z., Wang Q., Shim S., Chen Z.F., Song H.J., Mei L., Xiong W.C. Nat. Neurosci. 7:1204-1212(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DCC. |
| [33] | "Activation of FAK and Src are receptor-proximal events required for netrin signaling." Li W., Lee J., Vikis H.G., Lee S.H., Liu G., Aurandt J., Shen T.L., Fearon E.R., Guan J.L., Han M., Rao Y., Hong K., Guan K.L. Nat. Neurosci. 7:1213-1221(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DCC. |
| [34] | "Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis." Shen T.L., Park A.Y., Alcaraz A., Peng X., Jang I., Koni P., Flavell R.A., Gu H., Guan J.L. J. Cell Biol. 169:941-952(2005) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE, FUNCTION. |
| [35] | "Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness." Brown M.C., Cary L.A., Jamieson J.S., Cooper J.A., Turner C.E. Mol. Biol. Cell 16:4316-4328(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [36] | "Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation." Braren R., Hu H., Kim Y.H., Beggs H.E., Reichardt L.F., Wang R. J. Cell Biol. 172:151-162(2006) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE, FUNCTION. |
| [37] | "FAK potentiates Rac1 activation and localization to matrix adhesion sites: a role for betaPIX." Chang F., Lemmon C.A., Park D., Romer L.H. Mol. Biol. Cell 18:253-264(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN CELL SPREADING; PHOSPHORYLATION OF ARHGEF7; RAC1 TARGETING TO FOCAL ADHESIONS AND RAC1 ACTIVATION, INTERACTION WITH ARHGEF7. |
| [38] | "Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations." Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F., Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B., Panse C., Schlapbach R., Mansuy I.M. Mol. Cell. Proteomics 6:283-293(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-948, MASS SPECTROMETRY. Tissue: Brain cortex. |
| [39] | "Large-scale phosphorylation analysis of mouse liver." Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-614 AND TYR-615, MASS SPECTROMETRY. Tissue: Liver. |
| [40] | "Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation." Lim S.T., Chen X.L., Lim Y., Hanson D.A., Vo T.T., Howerton K., Larocque N., Fisher S.J., Schlaepfer D.D., Ilic D. Mol. Cell 29:9-22(2008) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE, FUNCTION IN REGULATION OF P53/TP53 LEVELS; CELL PROLIFERATION AND CELL SURVIVAL, INTERACTION WITH MDM2, SUBCELLULAR LOCATION. |
| [41] | "Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain." Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P. J. Proteome Res. 7:311-318(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-614; TYR-615 AND TYR-963, MASS SPECTROMETRY. Tissue: Brain. |
| [42] | "Transient expression of FRNK reveals stage-specific requirement for focal adhesion kinase activity in cardiac growth." DiMichele L.A., Hakim Z.S., Sayers R.L., Rojas M., Schwartz R.J., Mack C.P., Taylor J.M. Circ. Res. 104:1201-1208(2009) [PubMed] [Europe PMC] [Abstract] Cited for: DEVELOPMENTAL STAGE (ISOFORM 9). |
| [43] | "Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis." Chu P.Y., Huang L.Y., Hsu C.H., Liang C.C., Guan J.L., Hung T.H., Shen T.L. J. Biol. Chem. 284:20215-20226(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF GRB7, INTERACTION WITH GRB7. |
| [44] | "Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling." Pylayeva Y., Gillen K.M., Gerald W., Beggs H.E., Reichardt L.F., Giancotti F.G. J. Clin. Invest. 119:252-266(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN SRC-MEDIATED PHOSPHORYLATION OF BCAR1, ROLE IN DISEASE. |
| [45] | "Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways." Clemente C.F., Xavier-Neto J., Dalla Costa A.P., Consonni S.R., Antunes J.E., Rocco S.A., Pereira M.B., Judice C.C., Strauss B., Joazeiro P.P., Matos-Souza J.R., Franchini K.G. J. Mol. Cell. Cardiol. 52:493-501(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [46] | "The role of focal adhesion kinase in early development." Chatzizacharias N.A., Kouraklis G.P., Theocharis S.E. Histol. Histopathol. 25:1039-1055(2010) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON ROLE IN DEVELOPMENT. |
| [47] | "Focal adhesion kinase: exploring Fak structure to gain insight into function." Hall J.E., Fu W., Schaller M.D. Int. Rev. Cell Mol. Biol. 288:185-225(2011) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION; SUBUNIT; PHOSPHORYLATION AND ENZYME REGULATION. |
| [48] | "The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin." Hayashi I., Vuori K., Liddington R.C. Nat. Struct. Biol. 9:101-106(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 959-1084, INTERACTION WITH PXN. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M95408 mRNA. Translation: AAA37592.1. AB030035 mRNA. Translation: BAC53924.1. AB011499 mRNA. Translation: BAC53890.1. AK005468 mRNA. Translation: BAB24058.1. AK079821 mRNA. Translation: BAC37757.1. Different initiation. AK220543 mRNA. Translation: BAD90317.1. Different initiation. BC030180 mRNA. No translation available. AF025652 AF025651 Genomic DNA. Translation: AAB95262.1.AF025652 AF025650 Genomic DNA. Translation: AAB95263.1.U77074 Genomic DNA. Translation: AAB51229.1. | ||||||||||||||||||||||||
| IPI | IPI00113563. IPI00230629. IPI00338858. IPI00625418. IPI00875543. IPI00895208. IPI00895269. IPI00895396. | ||||||||||||||||||||||||
| PIR | A46166. | ||||||||||||||||||||||||
| RefSeq | NP_001123881.1. NM_001130409.1. NP_032008.2. NM_007982.2. | ||||||||||||||||||||||||
| UniGene | Mm.254494. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P34152. | ||||||||||||||||||||||||
| SMR | P34152. Positions 33-742, 959-1084. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | P34152. 5 interactions. | ||||||||||||||||||||||||
| MINT | MINT-141959. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P34152. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | P34152. | ||||||||||||||||||||||||
| PRIDE | P34152. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENSMUST00000110036; ENSMUSP00000105663; ENSMUSG00000022607. ENSMUST00000170939; ENSMUSP00000126764; ENSMUSG00000022607. | ||||||||||||||||||||||||
| GeneID | 14083. | ||||||||||||||||||||||||
| KEGG | mmu:14083. | ||||||||||||||||||||||||
| UCSC | uc007wbw.2. mouse. uc007wbx.2. mouse. uc007wby.2. mouse. uc007wbz.2. mouse. uc007wca.1. mouse. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 5747. | ||||||||||||||||||||||||
| MGI | MGI:95481. Ptk2. | ||||||||||||||||||||||||
| Rouge | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | COG0515. | ||||||||||||||||||||||||
| GeneTree | ENSGT00620000087791. | ||||||||||||||||||||||||
| HOVERGEN | HBG004018. | ||||||||||||||||||||||||
| InParanoid | P34152. | ||||||||||||||||||||||||
| KO | K05725. | ||||||||||||||||||||||||
| OMA | VQTNHYQ. | ||||||||||||||||||||||||
| OrthoDB | EOG4WH8K1. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| BRENDA | 2.7.10.2. 3474. | ||||||||||||||||||||||||
| Reactome | REACT_127416. Developmental Biology. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| Bgee | P34152. | ||||||||||||||||||||||||
| CleanEx | MM_PTK2. | ||||||||||||||||||||||||
| Genevestigator | P34152. | ||||||||||||||||||||||||
| GermOnline | ENSMUSG00000022607. Mus musculus. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR019749. Band_41_domain. IPR019748. FERM_central. IPR000299. FERM_domain. IPR005189. Focal_adhesion_kin_target_dom. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR008266. Tyr_kinase_AS. IPR020635. Tyr_kinase_cat_dom. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF00373. FERM_M. 1 hit. PF03623. Focal_AT. 1 hit. PF07714. Pkinase_Tyr. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR00109. TYRKINASE. | ||||||||||||||||||||||||
| ProDom | PD006413. Focal_adhesion_target_reg. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||||||||
| SMART | SM00295. B41. 1 hit. SM00219. TyrKc. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SUPFAM | SSF47031. FERM_3-hlx. 1 hit. SSF68993. Focal_AT. 1 hit. SSF56112. Kinase_like. 1 hit. | ||||||||||||||||||||||||
| PROSITE | PS00660. FERM_1. False negative. PS00661. FERM_2. 1 hit. PS50057. FERM_3. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| ChEMBL | CHEMBL1075288. | ||||||||||||||||||||||||
| ChiTaRS | PTK2. mouse. | ||||||||||||||||||||||||
| EvolutionaryTrace | P34152. | ||||||||||||||||||||||||
| NextBio | 285100. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | FAK1_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P34152 Secondary accession number(s): O08578 Q9DAW3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
